Exomind Therapy
Mental Health Management Group offers ExoMind® as a non-invasive neuromodulation service that may be considered as part of a structured psychiatric care plan. ExoMind is administered in an outpatient clinical setting and requires individualized psychiatric evaluation prior to initiation.
Interested in learning more? Join us for our complimentary ExoMind Educational Lunch. Seating is limited. Reserve your seat here.
What Is ExoMind?
ExoMind is an FDA-cleared, non-invasive neuromodulation treatment for depression, anxiety, PTSD, and OCD. It delivers targeted electromagnetic pulses to specific brain regions involved in mood and cognitive regulation. The service does not require anesthesia, nor is it a surgical procedure.
When clinically appropriate, ExoMind may be discussed as part of a broader treatment plan for individuals experiencing mood-related or anxiety-related concerns. Decisions regarding its use are made collaboratively following comprehensive evaluation.
Clinical Context and Considerations
ExoMind is offered within a psychiatric framework and is not a replacement for comprehensive mental health care. Individuals may continue therapy, medication management, or other recommended services as part of coordinated care.
While some emerging research explores neuromodulation in areas such as cognitive performance, ExoMind is provided within this practice for clinically evaluated mental health concerns. Any off-label considerations are addressed in accordance with professional and regulatory standards.
What to Expect During Treatment
Sessions are conducted in-office under clinical supervision. During treatment, individuals experience a tapping or mild sensation at the site of stimulation. Most sessions are brief, and patients remain awake and alert throughout.
Treatment schedules vary depending on individual circumstances and clinical recommendation. Follow-up appointments are used to monitor response and reassess ongoing care needs.
Safety and Screening
A full clinical screening is required before beginning ExoMind therapy. Individuals with certain medical implants, seizure history, or other neurological contraindications may not be eligible. Safety protocols are followed in accordance with professional guidelines.
Individual responses vary, and outcomes cannot be guaranteed. ExoMind is one component of a comprehensive care plan when clinically appropriate.
ExoMind is not appropriate for all individuals. Determination of suitability is based on clinical assessment, medical history, and review of current symptoms.
FAQs
Individual experiences vary. Some individuals report noticing changes during the course of treatment, while others may require additional time. Response depends on multiple clinical factors.
Treatment protocols vary depending on the individual’s needs and clinical judgment. The number and frequency of sessions are determined during the evaluation and reassessed as needed.
ExoMind may be integrated into an existing treatment plan. Any adjustments to medications must be made under the supervision of a licensed prescribing clinician.
Insurance coverage for ExoMind varies and may not be available. Patients are encouraged to contact the office directly to discuss payment options and eligibility.
Some individuals may experience mild, temporary side effects such as scalp discomfort or headache. Serious adverse events are uncommon but possible. All risks and contraindications are reviewed during the screening process.
Medical Disclaimer
The information provided on this page is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. Clinical services are provided following an individualized evaluation by a licensed healthcare professional.